Abstract
To determine whether treatment with agonists of glucagon-like peptide-1 receptor (GLP-1R) result in weight loss in overweight or obese patients with or without type 2 diabetes mellitus.
Originalsprog | Engelsk |
---|---|
Tidsskrift | B M J |
Vol/bind | 344 |
Sider (fra-til) | d7771 |
ISSN | 0959-8146 |
Status | Udgivet - 2012 |